View More Recent Stories
-
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
-
ClearPoint Neuro Inc.'s SmartFlow Neuro Cannula receives approval from EU MDR
-
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
-
Stifel Reiterates Buy Rating on Clearpoint Neuro Inc. (CLPT)
-
ClearPoint Neuro Inc. (CLPT) Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
-
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
-
Clearpoint Neuro Inc. (CLPT) PT Raised to $30 at Lake Street Capital Markets
-
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
-
ClearPoint Neuro, Inc. (CLPT) Misses Q3 EPS by 1c
-
ClearPoint Neuro Reports Third Quarter 2024 Results
-
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024
-
Clearpoint Neuro Inc. (CLPT) PT Raised to $15 at Lake Street Capital Markets
-
ClearPoint Neuro Inc. (CLPT) Announces Early Repayment of $10 Million Note
